New Risk • May 26
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.5% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (8.1% operating cash flow to total debt). Earnings have declined by 17% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.0% net profit margin). 공시 • Apr 24
Anshan Hifichem Co., Ltd., Annual General Meeting, May 15, 2026 Anshan Hifichem Co., Ltd., Annual General Meeting, May 15, 2026, at 13:00 China Standard Time. Location: No. 8, Yihao Road, Teng'ao Economic Development Zone, Haicheng, Anshan, Liaoning China 공시 • Mar 31
Anshan Hifichem Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026 Anshan Hifichem Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026 공시 • Dec 31
Anshan Hifichem Co., Ltd. to Report Fiscal Year 2025 Results on Apr 24, 2026 Anshan Hifichem Co., Ltd. announced that they will report fiscal year 2025 results on Apr 24, 2026 공시 • Sep 30
Anshan Hifichem Co., Ltd. to Report Q3, 2025 Results on Oct 22, 2025 Anshan Hifichem Co., Ltd. announced that they will report Q3, 2025 results on Oct 22, 2025 공시 • Jul 02
Anshan Hifichem Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025 Anshan Hifichem Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025 공시 • Apr 18
Anshan Hifichem Co., Ltd., Annual General Meeting, May 09, 2025 Anshan Hifichem Co., Ltd., Annual General Meeting, May 09, 2025, at 13:00 China Standard Time. Location: No. 8, Yihao Road, Teng'ao Economic Development Zone, Haicheng, Anshan, Liaoning China 공시 • Mar 31
Anshan Hifichem Co., Ltd. to Report Q1, 2025 Results on Apr 18, 2025 Anshan Hifichem Co., Ltd. announced that they will report Q1, 2025 results on Apr 18, 2025 공시 • Dec 31
Anshan Hifichem Co., Ltd. to Report Fiscal Year 2024 Results on Apr 18, 2025 Anshan Hifichem Co., Ltd. announced that they will report fiscal year 2024 results on Apr 18, 2025 Reported Earnings • Oct 25
Third quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.021 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.13 (up from CN¥0.021 in 3Q 2023). Revenue: CN¥415.5m (up 31% from 3Q 2023). Net income: CN¥53.0m (up CN¥45.1m from 3Q 2023). Profit margin: 13% (up from 2.5% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 31% After last week's 31% share price gain to CN¥13.06, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 35% over the past year. New Risk • Sep 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.8% average weekly change). 공시 • Sep 30
Anshan Hifichem Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Anshan Hifichem Co., Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024 공시 • Sep 21
Anshan Hifichem Co., Ltd. Announces 2024 Interim Profit Distribution Plan (A Shares),Payable September 26, 2024 Anshan Hifichem Co., Ltd. announced 2024 interim profit distribution plan to be implemented (A shares):Cash dividend/10 shares (tax included): CNY0.50000000. Record date: 25 September 2024, Ex-date: 26 September 2024, Payment date: 26 September 2024. New Risk • Sep 07
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 0.9% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 27
Second quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.007 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.13 (up from CN¥0.007 in 2Q 2023). Revenue: CN¥416.2m (up 35% from 2Q 2023). Net income: CN¥45.6m (up CN¥42.6m from 2Q 2023). Profit margin: 11% (up from 1.0% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. 공시 • Jun 29
Anshan Hifichem Co., Ltd. to Report First Half, 2024 Results on Aug 27, 2024 Anshan Hifichem Co., Ltd. announced that they will report first half, 2024 results on Aug 27, 2024 Reported Earnings • Apr 16
First quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.04 loss in 1Q 2023) First quarter 2024 results: EPS: CN¥0.05 (up from CN¥0.04 loss in 1Q 2023). Revenue: CN¥322.5m (up 22% from 1Q 2023). Net income: CN¥21.6m (up CN¥36.4m from 1Q 2023). Profit margin: 6.7% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. New Risk • Apr 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Large one-off items impacting financial results. 공시 • Mar 30
Anshan Hifichem Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024 Anshan Hifichem Co., Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024 공시 • Feb 09
Anshan Hifichem Co., Ltd., Annual General Meeting, Mar 01, 2024 Anshan Hifichem Co., Ltd., Annual General Meeting, Mar 01, 2024, at 13:00 China Standard Time. Location: No. 8, Yihao Road, Teng'ao Economic Development Zone, Haicheng, Anshan, Liaoning China New Risk • Feb 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Large one-off items impacting financial results. Reported Earnings • Feb 07
Full year 2023 earnings released: EPS: CN¥0.03 (vs CN¥0.01 loss in FY 2022) Full year 2023 results: EPS: CN¥0.03 (up from CN¥0.01 loss in FY 2022). Revenue: CN¥1.22b (flat on FY 2022). Net income: CN¥11.0m (up CN¥13.8m from FY 2022). Profit margin: 0.9% (up from net loss in FY 2022). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. New Risk • Feb 07
New major risk - Revenue and earnings growth Earnings have declined by 25% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. 공시 • Dec 29
Anshan Hifichem Co., Ltd. to Report Fiscal Year 2023 Results on Feb 29, 2024 Anshan Hifichem Co., Ltd. announced that they will report fiscal year 2023 results on Feb 29, 2024 New Risk • Dec 22
New major risk - Revenue and earnings growth Earnings have declined by 22% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Reported Earnings • Oct 27
Third quarter 2023 earnings released: EPS: CN¥0.021 (vs CN¥0.009 loss in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.021 (up from CN¥0.009 loss in 3Q 2022). Revenue: CN¥317.7m (up 7.1% from 3Q 2022). Net income: CN¥7.96m (up CN¥10.6m from 3Q 2022). Profit margin: 2.5% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. New Risk • Oct 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. 공시 • Sep 30
Anshan Hifichem Co., Ltd. to Report Q3, 2023 Results on Oct 27, 2023 Anshan Hifichem Co., Ltd. announced that they will report Q3, 2023 results on Oct 27, 2023 Reported Earnings • Aug 29
Second quarter 2023 earnings released: EPS: CN¥0.007 (vs CN¥0.002 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.007 (up from CN¥0.002 in 2Q 2022). Revenue: CN¥308.0m (flat on 2Q 2022). Net income: CN¥2.96m (up 188% from 2Q 2022). Profit margin: 1.0% (up from 0.3% in 2Q 2022). Reported Earnings • Apr 26
First quarter 2023 earnings released: CN¥0.04 loss per share (vs CN¥0.06 profit in 1Q 2022) First quarter 2023 results: CN¥0.04 loss per share (down from CN¥0.06 profit in 1Q 2022). Revenue: CN¥263.6m (down 18% from 1Q 2022). Net loss: CN¥14.8m (down 160% from profit in 1Q 2022). Board Change • Mar 14
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.